
NETTLE: The medical-grade neurotechnology wearable for PMS
For the first time, neuroscientists have developed a way to address debilitating PMS and menstrual pain symptoms without relying on drugs, hormones, or enduring severe side effects.

For the first time, neuroscientists have developed a way to address debilitating PMS and menstrual pain symptoms without relying on drugs, hormones, or enduring severe side effects.

Women are offered the opportunity to benefit from Carevix at the Peterborough City Hospital – North West Anglia NHS Foundation Trust.

GentleCath Air for Women with FeelClean Technology protects against urethral damage and the risk of UTIs.

Bryan Hsu is tackling an area of research that has long been neglected—menstrual products.

The company’s 8th AI model makes ultrasound easier for new ultrasound users to capture important fetal measurements

ATLANTA, June 20, 2024 (GLOBE NEWSWIRE) — Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces it has received its European Union Medical Device Regulation (EU MDR) certificate and CE Mark certification for four of its products.

Spineart recently announced it received FDA 510(k) clearance for its Scarlet AC-Ti secured anterior cervical cage.

New research suggests the HPV vaccine is preventing cancer in men, as well as in women, but fewer boys than girls are getting the shots in the United States.

The Leonardo Dual Diode Laser from Biolitec is an alternative for the treatment of genitourinary syndrome of menopause, according to new study results.

99.8% of cervical cancer cases are caused by persistent high-risk HPV infections, while the virus is also linked to throat and oral cancer, as well as fertility problems.